magolibero
..se la sà gira..
About Vicente Anido, Jr.
From 2001 to 2012, Dr. Anido was President, Chief Executive Officer and a Director of ISTA Pharmaceuticals, a US-based ophthalmic pharmaceutical company. Prior to this, he was general partner of Windamere Venture Partners, served as President and CEO of CombiChem, Inc., a biotechnology company, and was President of the Americas Region of Allergan, a specialty pharmaceutical company focusing on ophthalmology, dermatology and neuromuscular indications.
Dr. Anido currently serves on the Board of Directors of QLT Inc. and Depomed Inc., two NASDAQ-listed pharmaceutical companies, and was recently named Chairman of the Board of Directors of Aerie Pharmaceuticals, a US private ophthalmic company.
Dr. Anido received a B.S. in Pharmacy, an M.S. in Pharmacy Administration from West Virginia University and a Ph.D. in Pharmacy Administration from the University of Missouri.
Information on the 2013 Ordinary Shareholder Meeting is available on the Nicox internet website:
Nicox - Shareholder meetings.
ma proprio più recently di così non può esser la sua nomina in Aerie ; risale ad una ventina di giorni fa
http://www.aeriepharma.com/20130404_pressrelease.html
sembra come quasi che "qualcuno" lo stia piazzando qua e la ..all'interno di una strategia ben definita